Diagnostic biomarkers for rare subtype of kidney cancer
There are more than 10 different subtypes of renal cell [...]
Predictive factors for recurrence after complete metastasectomy in metastatic kidney cancer patients
In this retrospective study, published in Science Direct this month, [...]
Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma
In this video interview from Practice Update, Dr Brad McGregor [...]
The impact of COVID-19 on kidney cancer patients: Survey findings
This video discussion brings together Professor Jamie Landman, urologist from [...]
First-line immunotherapy combination treatments for metastatic kidney cancer
A meta-analysis of four major clinical trials of immunotherapy combinations [...]
Individualised axitinib dosing for patients with metastatic kidney cancer
In the following video interview with Practice Update, Dr Nancy [...]
Safety and efficacy of restarting immune checkpoint inhibitors after immune-related adverse events
Immune checkpoint inhibitors can cause a number of immune-related adverse [...]
Liquid biopsies for kidney cancer
New research from the Medical University of Graz in Austria [...]
Promising activity of pembrolizumab plus bevacizumab for metastatic kidney cancer
Results from a phase Ib/II study published in Journal of [...]
Research suggests that B cells also play a role in the response to immunotherapy
A recent paper published in the journal Nature earlier this [...]
